Compound ID | 2033
Synonym(s): Maxaquin | NY-198
Class: Fluoroquinolone
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | DNA synthesis inhibitor. Binds to type II topoisomerases, gyrase and topoisomerase IV to inhibitor DNA cleavage and ligation reactions; bacterial topoisomerase inhibitor |
| Description: | Synthetic quinoline derivative. Mostly topical use |
| Year first mentioned: | 1987 |
| Highest development stage: | Approved by FDA in 1992 |
| Development status: | Approved |
| Reason dropped: | Discontinued/Withdrawn in US; phototoxicity and central nervous system (CNS) effects |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/3948 |
| Guide to Pharmacology: | lomefloxacin |
| Citations: |
|